Back to Search
Start Over
Performance of Xpert ® MTB/RIF among tuberculosis outpatients in Lilongwe, Malawi.
- Source :
-
African journal of laboratory medicine [Afr J Lab Med] 2017 Mar 31; Vol. 6 (2), pp. 464. Date of Electronic Publication: 2017 Mar 31 (Print Publication: 2017). - Publication Year :
- 2017
-
Abstract
- Background: Xpert <superscript>®</superscript> MTB/RIF is a molecular test for the detection of Mycobacterium tuberculosis and rifampicin resistance. It is considered to be a great advance over smear microscopy and culture. However, there is very little information regarding the performance characteristics of Xpert MTB/RIF in Malawi.<br />Objective: We aimed to evaluate the performance of Xpert MTB/RIF in a Malawian setting.<br />Methods: Stored sputum pellets were processed on Xpert MTB/RIF between June 2012 and May 2014. Results were compared to mycobacteria growth indicator tube and Löwenstein-Jensen cultures, LED fluorescent microscopy and GenoType <superscript>®</superscript> MTBDR plus assay. Rifampicin resistance was confirmed by DNA sequencing.<br />Results: Of the 348 specimens with valid Xpert MTB/RIF results, 129/348 (37%) were smear-positive and 198/348 (57%) were culture-positive. Xpert MTB/RIF demonstrated a sensitivity of 93.8% (95% CI 89.4% - 96.8%) and specificity of 97.4% (95% CI 93.5% - 99.3%), with a positive predictive value of 97.8% (95% CI 94.6% - 99.4%) and a negative predictive value of 92.6% (95% CI 87.4% - 96.1%). Xpert MTB/RIF correctly identified 185/186 (99.5%) rifampicin-sensitive and 2/2 (100%) rifampicin-resistant M. tuberculosis strains. Mutations were not detected by sequencing in one isolate which was rifampicin resistant on Xpert MTB/RIF but sensitive on MTBDR plus . Four non-tuberculous mycobacteria grew from four smear-negative specimens, namely, M. avium ( n = 1) and M. intracellulare ( n = 3). No cross-reactivity was observed with any of the non-tuberculous mycobacteria when using Xpert MTB/RIF.<br />Conclusion: When fully implemented, Xpert MTB/RIF may have an impact on patient care in Malawi. The increased diagnostic yield of Xpert MTB/RIF over smear microscopy can increase laboratory-confirmed tuberculosis detection and ensure that treatment is given to appropriate individuals or groups.<br />Competing Interests: The authors declare that they have no financial or personal relationship(s) that may have inappropriately influenced them in writing this article.
Details
- Language :
- English
- ISSN :
- 2225-2002
- Volume :
- 6
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- African journal of laboratory medicine
- Publication Type :
- Academic Journal
- Accession number :
- 28879160
- Full Text :
- https://doi.org/10.4102/ajlm.v6i2.464